1335210-24-6

Basic information

• Product Name: (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid
• Synonyms: Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid, 2,3,5,7,11,11a-hexahydro-6-methoxy-3-methyl-5,7-dioxo-, (3S,11aR)-;(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-3-methyl-6-(methyloxy)-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide;(3S,11AR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid
• CAS NO: 1335210-24-6
• Molecular Formula: C₁₃H₁₄N₂O₆
• Molecular Weight: 294.26006
• EINECS: -0
• Mol File: 1335210-24-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 556.1±50.0 °C(Predicted)
• Appearance: /
• Density: 1.56±0.1 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 5.46±0.40(Predicted)
• CAS DataBase Reference: (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid(1335210-24-6)
• EPA Substance Registry System: (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid(1335210-24-6)

Safety Data

• Hazardous Substances Data: 1335210-24-6(Hazardous Substances Data)

Usage

General Description

"(3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid" is a complex chemical compound that has various potential applications because of its diverse chemical skeleton. The compound contains several functional groups, namely a methoxy group, a methyl group, two dioxo groups, a hexahydrooxazolo group, a pyridine ring, a pyrazine ring, and a carboxylic acid group. These functional groups indicate that the compound may have a plethora of applications from medicinal to material science. Despite its complex structure, it is a potentially important and valuable compound in different fields of organic chemistry, pharmaceutical sciences, and materials. Please note that specific properties, usage, or safety information about this particular chemical compound may not be readily available as it may not have been fully characterized or studied yet.

Upstream product

• 2799-17-9 (S)-1-amino-2-propanol 
• 1335210-23-5 1-[2,2-bis(methyloxy)ethyl]-5-(methyloxy)-6-[(methyloxy)carbonyl]-4-oxo-1,4-dihydro-3-pyridinecarboxylic acid 
• 2749-11-3 (S)-Alaninol 
• 1335210-26-8 methyl 2-(((2,2-dimethoxyethyl)amino)methylene)-4-methoxy-3-oxobutanoate 
• 127958-23-0 methyl 2-[(dimethylamino)methylene]-4-methoxy-3-oxobutanoate 
• 41051-15-4 4-methoxyacetoacetic acid methylester 

Downstream Products

• 1335210-25-7 (4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b]oxazine-9-carboxamide 
• 1051375-10-0 (3S,11aR)-N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide 

Relevant articles and documents

Cabotegravir derivative with biological activity as well as preparation method and application thereof

The invention belongs to the technical field of chemical synthesis of medicines, and particularly relates to a cabotegravir derivative with biological activity as well as a preparation method and application thereof. The structural formula of the cabotegravir derivative is shown in the specification, wherein R1 is methyl or hydrogen; R2 is methylene, isopropyl, phenyl, benzyl, a nitrogen-containing heterocyclic ring, a sulfur-containing heterocyclic ring or an oxygen-containing heterocyclic ring; and R3 is hydrogen, methyl, ethyl, phenyl, benzyl, nitrogen-containing heterocyclic ring, sulfur-containing heterocyclic ring or oxygen-containing heterocyclic ring. The preparation method comprises the following steps of: carrying out deprotection on 1-(2, 2-dimethoxyethyl)-1, 4-dihydro-3-methoxy-4-oxo-2, 5-pyridinedicarboxylic acid-2-methyl ester to obtain aldehyde, cyclizing the aldehyde with aminobutanol, and carrying out acylation reaction on the cyclized aldehyde and an amino compound; or firstly reacting the aldehyde with an amino compound, and then cyclizing with aminopropanol; and finally, carrying out click reaction with azide to obtain a target compound. The derivative provided by the invention has proliferation inhibition activity on human tumor cells.

An Efficient and Highly Diastereoselective Synthesis of GSK1265744, a Potent HIV Integrase Inhibitor

A novel synthesis of GSK1265744, a potent HIV integrase inhibitor, is described. The synthesis is highlighted by an efficient construction of the densely functionalized pyridinone core as well as a highly diastereoselective formation of the acyl oxazolidine moiety. The latter exploits the target molecules ability to chelate to Mg2+, a key feature in the integrase inhibitors mechanism of action.